ICON Stock

ICON CROIC

The Cash Return on Invested Capital (CROIC) of ICON (ICLR) as of Aug 17, 2026 is 9.38 %. In the previous year, Cash Return on Invested Capital (CROIC) was 8.64 % — a change of 8.54% (higher).

CROIC

9.38 %

YoY

8.54%

Last updated:

Cash Return on Invested Capital (CROIC) of ICON is 2026 9.38 % . Cash Return on Invested Capital (CROIC) of ICON was 2025 8.64 % . It decreases by 8.54% higher compared to the previous year.
Access this data via the Eulerpool API

ICON Stock analysis

What does ICON do? ICON PLC is a global company specializing in clinical research and development of pharmaceuticals. The company was founded in 1990 and is headquartered in Dublin, Ireland. It was formed through the merger of several smaller companies. Today, ICON PLC is one of the world's leading companies in the field of clinical trials. ICON is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ICON stock

Cash Return on Invested Capital (CROIC) of ICON is 9.38 % in 2026.

Cash Return on Invested Capital (CROIC) of ICON changed from 8.64 % to 9.38 %, representing a 8.54% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) ICON since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s ICON with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

Profitability — ICON

All Key Metrics — ICON